Dash Acquisitions Inc. Takes $5.09 Million Position in Zoetis Inc. $ZTS

Key Points

• Dash Acquisitions Inc. acquired a $5.09 million stake in Zoetis Inc., purchasing 33,163 shares, which constitutes about 1.1% of its investment portfolio.
• Analyst ratings for Zoetis have seen fluctuations, with some firms lowering their price targets, including Leerink Partners reducing it from $180 to $155.
• Zoetis recently announced a quarterly dividend of $0.50 per share, amounting to an annualized dividend of $2.00 and a yield of 1.4%.

Dash Acquisitions Inc. acquired a new stake in shares of Zoetis Inc. (NYSE:ZTS - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 33,163 shares of the company's stock, valued at approximately $5,089,000. Zoetis comprises about 1.1% of Dash Acquisitions Inc.'s investment portfolio, making the stock its 23rd biggest holding.

Several other institutional investors have also added to or reduced their stakes in ZTS. Lindbrook Capital LLC lifted its stake in shares of Zoetis by 1.8% during the 1st quarter. Lindbrook Capital LLC now owns 3,715 shares of the company's stock valued at $612,000 after buying an additional 65 shares in the last quarter. Scott & Selber Inc. lifted its position in shares of Zoetis by 0.6% during the second quarter. Scott & Selber Inc. now owns 11,652 shares of the company's stock worth $1,817,000 after acquiring an additional 67 shares in the last quarter. Secure Asset Management LLC boosted its stake in Zoetis by 2.9% in the 2nd quarter. Secure Asset Management LLC now owns 2,448 shares of the company's stock worth $382,000 after purchasing an additional 68 shares during the period. Quotient Wealth Partners LLC boosted its stake in Zoetis by 2.3% in the 1st quarter. Quotient Wealth Partners LLC now owns 3,167 shares of the company's stock worth $521,000 after purchasing an additional 72 shares during the period. Finally, Menard Financial Group LLC lifted its holdings in shares of Zoetis by 3.8% in the first quarter. Menard Financial Group LLC now owns 2,032 shares of the company's stock worth $305,000 after buying an additional 75 shares in the last quarter. 92.80% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

ZTS has been the topic of several recent analyst reports. Leerink Partners cut shares of Zoetis from an "outperform" rating to a "market perform" rating and lowered their target price for the stock from $180.00 to $155.00 in a research note on Thursday, July 17th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Zoetis in a research report on Wednesday, October 8th. Stifel Nicolaus cut Zoetis from a "buy" rating to a "hold" rating and lowered their price target for the company from $165.00 to $160.00 in a report on Wednesday, June 18th. Piper Sandler raised their price target on Zoetis from $210.00 to $215.00 and gave the company an "overweight" rating in a report on Monday, August 11th. Finally, Leerink Partnrs cut Zoetis from a "strong-buy" rating to a "hold" rating in a report on Thursday, July 17th. Four analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $196.71.

Zoetis Stock Performance

Shares of NYSE ZTS opened at $143.45 on Wednesday. The stock has a market cap of $63.58 billion, a price-to-earnings ratio of 24.69, a P/E/G ratio of 2.28 and a beta of 0.90. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05. Zoetis Inc. has a 1-year low of $139.34 and a 1-year high of $196.55. The stock's 50-day moving average is $148.98 and its 200 day moving average is $154.11.

Zoetis (NYSE:ZTS - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $1.76 EPS for the quarter, topping the consensus estimate of $1.62 by $0.14. The firm had revenue of $2.46 billion for the quarter, compared to the consensus estimate of $2.41 billion. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The business's revenue was up 4.2% compared to the same quarter last year. During the same period last year, the firm posted $1.56 earnings per share. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, sell-side analysts anticipate that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 2nd. Investors of record on Friday, October 31st will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date is Friday, October 31st. Zoetis's dividend payout ratio (DPR) is presently 34.42%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.